Application 021677
- Type
- NDA
- Sponsor
- LILLY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALIMTA | PEMETREXED | INJECTABLE; INJECTION | 500MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pemfexy | PEMETREXED | Acacia Pharma, Ltd. | caef07ce-066b-4c48-98dc-974b05ebbbe0 | 2026-06-18 | Warnings, Adverse reactions | PEMETREXED |
| Pemfexy | PEMETREXED | Eagle Pharmaceuticals, Inc. | 2308f4e8-21c8-49c1-a5b8-deb8610bac6a | 2026-02-20 | Warnings, Adverse reactions | PEMETREXED |
| Pemetrexed | PEMETREXED | Solco Healthcare US, LLC | bd0ada98-3237-4465-8ba2-3a12c33116fb | 2025-12-31 | Warnings, Adverse reactions | PEMETREXED |
| PEMETREXED | PEMETREXED | Hospira, Inc. | 3ae68628-7ab0-4491-b3ae-6a8330b719c8 | 2025-10-08 | Warnings, Adverse reactions | PEMETREXED |
| AXTLE | PEMETREXED | Avyxa Pharma, LLC | 9582c46c-d8b0-44b7-a2ee-9c86f5e9b7b1 | 2025-10-08 | Warnings, Adverse reactions | PEMETREXED |
| PEMETREXED | PEMETREXED | Hospira, Inc. | 3e087418-69ff-47fa-93c2-f28699309433 | 2024-07-24 | Warnings, Adverse reactions | PEMETREXED |
| PEMETREXED | PEMETREXED | Accord Healthcare Inc. | dfd19e67-54cb-c062-e053-2995a90a294a | 2024-07-18 | Warnings, Adverse reactions | PEMETREXED |
| Pemetrexed | PEMETREXED | BluePoint Laboratories | 495c6751-8d6f-4093-8108-9bed283fce03 | 2023-09-05 | Warnings, Adverse reactions | PEMETREXED |
| Pemetrexed | PEMETREXED | Eugia US LLC | 737ead51-f73c-414f-b68f-d3affc27a225 | 2023-07-27 | Warnings, Adverse reactions | PEMETREXED |
| Alimta | PEMETREXED DISODIUM | Eli Lilly and Company | f5a860f3-37ec-429c-ae04-9c88d7c55c08 | 2023-05-19 | Warnings, Adverse reactions | Alimta |
| Pemetrexed | PEMETREXED | Teva Pharmaceuticals, Inc. | 8b660f68-b770-4e0a-b2f9-25e663deecc3 | 2022-12-01 | Warnings, Adverse reactions | PEMETREXED |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.